Emergent BioSolutions Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (38)

Latest Posts

About This Stock More About This Stock
Monkeypox Outbreak Puts Focus On These Two Biotechs
Article By: InvestorsAlley
Friday, May 27, 2022 8:30 AM EDT
Just when you thought it was safe to go outside, monkeypox pops up. Still, this might not be bad news for the market, as the world will turn once again to vaccine makers to find a solution.
In this article: EBS, BVNRY
Read
J&J Assumes Responsibility Of Vaccine Manufacturing At Emergent Facility
Article By: The Fly
Monday, April 5, 2021 7:50 AM EDT
Johnson & Johnson announced on Saturday that it is assuming full responsibility regarding the manufacturing of drug substances for its COVID-19 vaccine at the Emergent BioSolutions Bayview facility.
In this article: EBS, JNJ
Read
Emergent Says Treatment For Hospitalized Covid Patients Shows No Benefit
Article By: The Fly
Saturday, April 3, 2021 4:31 PM EDT
Emergent BioSolutions provided an update on the evaluation of its investigational SARS-CoV-2 immune globulin intravenous, or COVID-HIG, for the treatment of hospitalized patients with COVID-19.
In this article: EBS
Read
Quick Reminder: Insider Trading Does Not Maximize Shareholder Value
Article By: Dean Baker
Sunday, July 26, 2020 7:39 PM EDT
Insider trading effectively means top executives are stealing from the companies they run. Excitement over potential covid vaccines may be causing irregularities at at least 9 biopharmas, according to the NYT.
In this article: VXRT, REGN, MRNA, NVAX, LMNX, QDEL, EBS, INO
Read
4 Biotech Stocks To Watch In The New Year
Article By: Zacks Investment Research
Sunday, January 7, 2018 5:23 PM EDT
Biotech companies are continuously working on bringing innovative new treatments to market, and there could be significant catalysts in the coming quarters in the form of important product approvals as well as major data read-outs.
In this article: EBS, GSK, MDCO, XOMA, EXEL, NVS, MLNT
Read

Latest Tweets for $EBS

No tweets yet!

PARTNER HEADLINES